表紙：男性型脱毛症治療の世界市場：薬剤タイプ、投与経路、男女、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

市場調査レポート

商品コード

1085794

男性型脱毛症治療の世界市場：薬剤タイプ、投与経路、男女、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

Androgenetic Alopecia Treatment Market, by Drug Type, by Route of Administration, by Gender, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月22日 | 発行: Coherent Market Insights

| ページ情報: 英文 195 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 705,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,097,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,567,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

男性型脱毛症の発生率の増加が、世界の男性型脱毛症治療市場の成長を促進すると期待されています。しかし、代替治療法の利用が可能であることが、市場の成長を妨げると予測されています。

当レポートでは、世界の男性型脱毛症治療市場について調査分析し、市場概要、市場力学、動向、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

ヒートマップ分析
市場シェア分析
- Histogen Inc.
- Cipla Limited
- Aclaris Therapeutics, Inc.
- Merck &Co., Inc.
- Daiichi-Sankyo Co., Ltd.
- Johnson and Johnson Services, Inc.
- Lexington International LLC
- Vita-Cos-Med Klett-Loch GmbH
- PureTech
- Vitabiotics
- Dr. Reddy's Laboratories
- Ranbaxy Laboratories Ltd
- HCell Inc.
- Follica, Inc.
- Analyst Views

第11章セクション

Product Code: CMI4316

Androgenetic alopecia, a slow progressive form of alopecia, begins after the onset of puberty. Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens that affects up to 50% of males and females globally, according to the National Center for Biotechnology Information (NCBI). It is characterized by progressive loss of terminal hair of the scalp, in a characteristic distribution in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, while in women the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair.

Market Dynamics

Rising incidence of androgenetic alopecia is expected to drive the global androgenetic alopecia treatment market growth. According to the National Library of Medicine (NLM), a medical library which is part of the National Institutes of Health (NIH), androgenetic alopecia affects approximately 50 million men and 30 million women in the U.S.

However, availability of alternative treatments is expected to hinder the market growth. For instance, hair restoration surgery such as scalp reduction surgeries, which is not used frequently but efficacy of hair transplantation is based on the principle of donor dominance.

Key features of the study:

This report provides in-depth analysis of the global androgenetic alopecia treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global androgenetic alopecia treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy's Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. among others

Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics

The global androgenetic alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global androgenetic alopecia treatment market.

Detailed Segmentation:

Global Androgenetic Alopecia Treatment Market, By Drug Type:
- Topical Agents
- 5 AR Inhibitors
- Others
Global Androgenetic Alopecia Treatment Market, By Route of Administration:
- Oral
- Topical
Global Androgenetic Alopecia Treatment Market, By Gender:
- Male
- Female
Global Androgenetic Alopecia Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Androgenetic Alopecia Treatment Market, By Region:
- North America
  - By Drug Type:
  - Topical Agents
  - 5 AR Inhibitors
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - By Gender:
  - Male
  - Female
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Drug Type:
  - Topical Agents
  - 5 AR Inhibitors
  - Corticosteroids
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injectable
  - By Gender:
  - Male
  - Female
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Drug Type:
  - Topical Agents
  - 5 AR Inhibitors
  - Corticosteroids
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injectable
  - By Gender:
  - Male
  - Female
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Drug Type:
  - Topical Agents
  - 5 AR Inhibitors
  - Corticosteroids
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injectable
  - By Gender:
  - Male
  - Female
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Drug Type:
  - Topical Agents
  - 5 AR Inhibitors
  - Corticosteroids
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injectable
  - By Gender:
  - Male
  - Female
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Drug Type:
  - Topical Agents
  - 5 AR Inhibitors
  - Corticosteroids
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injectable
  - By Gender:
  - Male
  - Female
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Histogen Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Cipla Limited
- Aclaris Therapeutics, Inc.
- Merck & Co., Inc.
- Daiichi-Sankyo Co., Ltd.
- Johnson and Johnson Services, Inc.
- Lexington International LLC
- Vita-Cos-Med Klett-Loch GmbH
- PureTech
- Vitabiotics
- Dr. Reddy's Laboratories
- Ranbaxy Laboratories Ltd
- HCell Inc.
- Follica, Inc.

"" marked represents similar segmentation in other categories in the respective section.*

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Gender
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Androgenetic Alopecia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Market Scenario
Impact of COVID-19 Market on the Androgenetic Alopecia Treatment Products

5. Global Androgenetic Alopecia Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Topical Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Androgenetic Alopecia Treatment Market, By Route of Administration, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Androgenetic Alopecia Treatment Market, By Gender, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Androgenetic Alopecia Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

9. Global Androgenetic Alopecia Treatment Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Histogen Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aclaris Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Daiichi-Sankyo Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson and Johnson Services, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lexington International LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vita-Cos-Med Klett-Loch GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PureTech
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vitabiotics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ranbaxy Laboratories Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- HCell Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Follica, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views

11. Section

References
Research Methodology
About us and Sales Contact

男性型脱毛症治療の世界市場：薬剤タイプ、投与経路、男女、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

Androgenetic Alopecia Treatment Market, by Drug Type, by Route of Administration, by Gender, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学・規制・動向分析

第4章世界の男性型脱毛症治療市場：コロナウイルス（COVID-19）パンデミックの影響

第5章世界の男性型脱毛症治療市場：薬剤タイプ別（2017年～2028年）

第6章世界の男性型脱毛症治療市場：投与経路別（2017年～2028年）

第7章世界の男性型脱毛症治療市場：男女別（2017年～2028年）

第8章世界の男性型脱毛症治療市場：流通チャネル別（2017年～2028年）

第9章世界の男性型脱毛症治療市場：地域別（2017年～2028年）

第10章競合情勢

第11章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

"" marked represents similar segmentation in other categories in the respective section.*

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Androgenetic Alopecia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Androgenetic Alopecia Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

6. Global Androgenetic Alopecia Treatment Market, By Route of Administration, 2017 - 2028, (US$ Mn)

7. Global Androgenetic Alopecia Treatment Market, By Gender, 2017 - 2028, (US$ Mn)

8. Global Androgenetic Alopecia Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

9. Global Androgenetic Alopecia Treatment Market, By Region, 2017 - 2028, (US$ Mn)

10. Competitive Landscape

11. Section

男性型脱毛症治療の世界市場：薬剤タイプ、投与経路、男女、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

Androgenetic Alopecia Treatment Market, by Drug Type, by Route of Administration, by Gender, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場の展望

第3章 市場力学・規制・動向分析

第4章 世界の男性型脱毛症治療市場：コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の男性型脱毛症治療市場：薬剤タイプ別（2017年～2028年）

第6章 世界の男性型脱毛症治療市場：投与経路別（2017年～2028年）

第7章 世界の男性型脱毛症治療市場：男女別（2017年～2028年）

第8章 世界の男性型脱毛症治療市場：流通チャネル別（2017年～2028年）

第9章 世界の男性型脱毛症治療市場：地域別（2017年～2028年）

第10章 競合情勢

第11章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Androgenetic Alopecia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Androgenetic Alopecia Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

6. Global Androgenetic Alopecia Treatment Market, By Route of Administration, 2017 - 2028, (US$ Mn)

7. Global Androgenetic Alopecia Treatment Market, By Gender, 2017 - 2028, (US$ Mn)

8. Global Androgenetic Alopecia Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

9. Global Androgenetic Alopecia Treatment Market, By Region, 2017 - 2028, (US$ Mn)

10. Competitive Landscape

11. Section

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学・規制・動向分析

第4章世界の男性型脱毛症治療市場：コロナウイルス（COVID-19）パンデミックの影響

第5章世界の男性型脱毛症治療市場：薬剤タイプ別（2017年～2028年）

第6章世界の男性型脱毛症治療市場：投与経路別（2017年～2028年）

第7章世界の男性型脱毛症治療市場：男女別（2017年～2028年）

第8章世界の男性型脱毛症治療市場：流通チャネル別（2017年～2028年）

第9章世界の男性型脱毛症治療市場：地域別（2017年～2028年）

第10章競合情勢

第11章セクション

"" marked represents similar segmentation in other categories in the respective section.*